MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-13
DOI
10.1038/s41388-021-02007-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correction: Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1
- (2019) Subhasis Das et al. ONCOGENE
- Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion
- (2019) Laura M. Prolo et al. Scientific Reports
- The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons
- (2017) Martin Larhammar et al. JOURNAL OF NEUROSCIENCE
- MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance
- (2017) Xuan Gao et al. Molecular Oncology
- MAP4K4 deficiency in CD4 + T cells aggravates lung damage induced by ozone-oxidized black carbon particles
- (2016) Ming Jin et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Endothelial Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 Is Critical for Lymphatic Vascular Development and Function
- (2016) Rachel J. Roth Flach et al. MOLECULAR AND CELLULAR BIOLOGY
- Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer
- (2016) Sandeep Kumar et al. Molecular Oncology
- Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma
- (2016) Xianda Zhao et al. Oncotarget
- MAP4K4: an emerging therapeutic target in cancer
- (2016) Xuan Gao et al. Cell and Bioscience
- MLK3 Signaling in Cancer Invasion
- (2016) Chotirat Rattanasinchai et al. Cancers
- MAP4K4 Is a Threonine Kinase That Phosphorylates FARP1
- (2015) Adam G. Schwaid et al. ACS Chemical Biology
- Neuritogenic Militarinone-Inspired 4-Hydroxypyridones Target the Stress Pathway Kinase MAP4K4
- (2015) Peter Schröder et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival
- (2015) Subhasis Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MAP4K4 regulates integrin-FERM binding to control endothelial cell motility
- (2015) Philip Vitorino et al. NATURE
- Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis
- (2015) Chudi O. Ndubaku et al. ACS Medicinal Chemistry Letters
- Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis
- (2015) Rachel J. Roth Flach et al. Nature Communications
- Microtubules Regulate Focal Adhesion Dynamics through MAP4K4
- (2014) Jiping Yue et al. DEVELOPMENTAL CELL
- HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance
- (2014) Huai-Chia Chuang et al. Nature Communications
- Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
- (2013) María P. Torres et al. PLoS One
- Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function
- (2012) V. Rangasamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estrogen Suppresses MLK3-Mediated Apoptosis Sensitivity in ER+ Breast Cancer Cells
- (2010) V. Rangasamy et al. CANCER RESEARCH
- Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
- (2009) Myriam Aouadi et al. NATURE
- The mammalian family of sterile 20p-like protein kinases
- (2009) Eric Delpire PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Anti-Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis
- (2008) J.-H. Egberts et al. CANCER RESEARCH
- Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
- (2008) J. J. Liang et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started